These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4919553)

  • 41. [Use of glucagon in cardiac glycoside poisoning in patients with congestive circulatory insufficiency].
    Sivkov SI
    Kardiologiia; 1977 Sep; 17(9):39-42. PubMed ID: 926598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The clinical use of a new cardioactive glycoside: proscillaridin A].
    Maiorano G; Arbore S
    Minerva Med; 1967 Dec; 58(96):4243-6. PubMed ID: 6083285
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative analysis of the transient effects of cardiac glycosides (convallatoxol, cymarol and g-strophantin)].
    Schmidt H; Fiehring H; Assmann I; Hesse P; Banse P
    Z Gesamte Inn Med; 1970 Oct; 25(19):902-4. PubMed ID: 5535433
    [No Abstract]   [Full Text] [Related]  

  • 44. [Optimization of therapy using cardiac glycosides].
    Ziesenhenn K; Behn P
    Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.
    Dikshit K; Vyden JK; Forrester JS; Chatterjee K; Prakash R; Swan HJ
    N Engl J Med; 1973 May; 288(21):1087-90. PubMed ID: 4697939
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. A hemodynamic, volumetric, and metabolic study in patients without heart failure.
    DeMots H; Rahimtoola SH; Kremkau EL; Bennett W; Mahler D
    J Clin Invest; 1976 Aug; 58(2):312-9. PubMed ID: 783197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of intravenous morphine in patients with mitral valvular disease and congestive heart failure.
    Grendahl H; Andersen A; Müller C
    Acta Med Scand; 1973; 1-2(1):69-74. PubMed ID: 4727250
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute coronary occlusion in pigs: effects of acetyl strophanthidin.
    Hood WB; Covelli VH; Norman JC
    Cardiovasc Res; 1969 Oct; 3(4):441-6. PubMed ID: 5360372
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 51. [Acute hemodynamic effects of alifedrine in patients with heart failure].
    Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K
    Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The therapy of cardiac insufficiency using Theo-Alvonal].
    Kettermann W
    Munch Med Wochenschr; 1968 Jan; 110(4):228-32. PubMed ID: 5695033
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of oleandrin on cardiovascular hemodynamics in the dog.
    Deavers SI; Rosborough JP; Hoff HE; McCrady JD
    Am J Vet Res; 1979 Oct; 40(10):1421-5. PubMed ID: 575023
    [No Abstract]   [Full Text] [Related]  

  • 54. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death.
    Feng Q; Leong WS; Liu L; Chan WI
    Molecules; 2016 Apr; 21(4):534. PubMed ID: 27110755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of cardiac glycosides on 24-h ambulatory blood pressure in healthy volunteers and patients with heart failure.
    Grossmann M
    Eur J Clin Invest; 2001; 31 Suppl 2():26-30. PubMed ID: 11525235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical evaluation of glucagon by continuous infusion in the treatment of low cardiac output states.
    Vander Ark CR; Reynolds EW
    Am Heart J; 1970 Apr; 79(4):481-7. PubMed ID: 5418021
    [No Abstract]   [Full Text] [Related]  

  • 58. A clinical study of the effect of coenzyme Q on congestive heart failure.
    Ishiyama T; Morita Y; Toyama S; Yamagami T; Tsukamoto N
    Jpn Heart J; 1976 Jan; 17(1):32-42. PubMed ID: 778433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of kidney or liver disorders on the serum concentration and urinary excretion of 3H-peruvoside, a tritium-labelled cardiac glycoside.
    Lahrtz H; van Zwieten PA
    Eur J Pharmacol; 1968 May; 3(2):147-52. PubMed ID: 5666010
    [No Abstract]   [Full Text] [Related]  

  • 60. The question of dosage and method of administration of cardiac glycosides in cases of cardiac failure.
    Toyama S; Suzuki K
    Jpn Circ J; 1986 Jul; 50(7):622-7. PubMed ID: 3773228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.